TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis (Q39239250)

10 September 2017

title

TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis (English)

1 reference

10 September 2017

author name string

Syam Prakash Somasekharan

1

1 reference

10 September 2017

Michal Koc

2

1 reference

10 September 2017

Alexandre Morizot

3

1 reference

10 September 2017

Olivier Micheau

4

1 reference

10 September 2017

Poul H B Sorensen

5

1 reference

10 September 2017

Olivier Gaide

6

1 reference

10 September 2017

Ladislav Andera

7

1 reference

10 September 2017

Jean-Claude Martinou

8

1 reference

10 September 2017

language of work or name

1 reference

1 March 2013

1 reference

10 September 2017

1 reference

10 September 2017

volume

18

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

324-336

1 reference

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

New insights into apoptosis signaling by Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Mitochondria as the central control point of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

BH3-only proteins in cell death initiation, malignant disease and anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

The TRAIL apoptotic pathway in cancer onset, progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Role of BAX in the apoptotic response to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Rho kinase in the regulation of cell death and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Marginal blebbing during the early stages of TNF-induced apoptosis indicates alteration in actomyosin contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Cell motility through plasma membrane blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Actin-binding protein requirement for cortical stability and efficient locomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Mechanisms of cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Collective cell migration in morphogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Blebs lead the way: how to migrate without lamellipodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase signalling controls microglia activation and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8(+) T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Cross talk between apoptosis and invasion signaling in cancer cells through caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Platelet formation is the consequence of caspase activation within megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Non-apoptotic functions of caspases in cellular proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Caspases in cell survival, proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

X-linked IAP is a direct inhibitor of cell-death proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0782-6

10.1007/S10495-012-0782-6

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference